SB-258585 dihydrochloride, >=98% (HPLC), powder

SB-258585 dihydrochloride, >=98% (HPLC), powder

Biochem/physiol Actions

5-HT6 serotonin receptor antagonist.

Features and Benefits

This compound was developed by GlaxoSmithKline. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Legal Information

Sold for research purposes under agreement from GlaxoSmithKline

Packaging

10, 50 mg in glass bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Quality Level InChI key InChI Manufacturer Further Info Form Assay Price Quantity
3573893 SB-258585 dihydrochloride, >=98% (HPLC), powder white to beige 100 QDYGVTFRTVLFCD-UHFFFAOYSA-N 1S/C18H22IN3O3S.2ClH/c1-21-9-11-22(12-10-21)17-13-15(5-8-18(17)25-2)20-26(23,24)16-6-3-14(19)4-7-16;;/h3-8,13,20H,9-12H2,1-2H3;2*1H SIGMA-ALDRICH Store under nitrogen; package with desiccants at 4°C powder ≥98% (HPLC)
£309.21 (exc VAT) per 10MG
-
+
3573894 SB-258585 dihydrochloride, >=98% (HPLC), powder white to beige 100 QDYGVTFRTVLFCD-UHFFFAOYSA-N 1S/C18H22IN3O3S.2ClH/c1-21-9-11-22(12-10-21)17-13-15(5-8-18(17)25-2)20-26(23,24)16-6-3-14(19)4-7-16;;/h3-8,13,20H,9-12H2,1-2H3;2*1H SIGMA-ALDRICH Store under nitrogen; package with desiccants at 4°C powder ≥98% (HPLC)
£897.00 (exc VAT) per 50MG
-
+